Choosing Between BCMA and Non-BCMA Bispecifics in Multiple Myeloma Treatment

Video

Experts explain the strategies for optimal selection between different BCMA-targeting and non-BCMA-targeting bispecifics for the treatment of relapsed/refractory multiple myeloma.

CN_MM_TrainingAcademy6 _Seg10_CHOICE
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Content